Companies · Other Health Care

Channel Medsystems, Inc.

BERKELEY · Other Health Care

Diligence memoA one-page analyst read on Channel Medsystems, Inc. — recommendation, valuation, rhythm, risks.
$54.7M
Total raised · real
5
Rounds
0.5×
Latest step-up
Top 8%
Sector rank · raised
Series B
Latest stage · inferred · Fri Mar 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Channel Medsystems, Inc. looks under-valued against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.24× the median modeled value of Series B Other Health Care companies in 2022–2024 (91 peers) — value vs value, same stage and era.
At-risk
  • Last raise 2.3 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Channel Medsystems, Inc. is one of 5376 Other Health Care companies tracked from BERKELEY. By capital raised it ranks among the largest (ahead of 93% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2024-03-15
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries A · 2013-04-19 Raised $9.8M (real) Modeled valuation $197M (est)$9.8M$197MSeries A2013Series A · 2014-10-07 Raised $6.0M (real) Modeled valuation $121M (est)$6.0M$121MSeries A2014Series B · 2015-07-08 Raised $24M (real) Modeled valuation $529M (est)$24M$529MSeries B2015Series B · 2023-04-19 Raised $10M (real) Modeled valuation $94M (est)$10M$94MSeries B2023Series B · 2024-03-15 Raised $5.0M (real) Modeled valuation $36M (est)$5.0M$36MSeries B2024+$6.0M+$24M+$10M+$5.0MCumulative $55M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$9.8M · 2013
Series A extension$6.0M · 2014
Series B$23.9M · 2015
Series B extension$10.0M · 2023
Series B extension$5.0M · 2024

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$35.8M
Base estimate est.
$11.8M
Conservative case
$67.7M
Upside case
$27.8M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $197.5M · 2013-04-192013Series A · modeled $121.1M · 2014-10-07Series B · modeled $528.7M · 2015-07-08Series B · modeled $94.4M · 2023-04-19Series B · modeled $35.8M · 2024-03-152024
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
2.3 yr
Elapsed time used
2.3 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
33 mo
Avg between rounds
$5.0M/yr
Capital velocity
13.2 yr
On record since
2013
First round
5
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 22× above median
This company$54.7M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.3× of median
This company$5.0M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 1.6× above median
This company$35.8M
Sector median$22.1M

Raised more than 93% of sector peers (real $). Modeled value above 61% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #81 of 91.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0M$100.0MCapital raised (log)Code Biotherapeutics, Inc. · Series B Raised $47.5M · modeled $465.5M (est)Candesant Biomedical, Inc. · Series B Raised $44.5M · modeled $455.0M (est)Artis Holdings, LLC · Series B Raised $40.0M · modeled $383.2M (est)GIO Blood Ltd · Series B Raised $27.3M · modeled $375.2M (est)Clarapath, Inc. · Series B Raised $40.2M · modeled $348.1M (est)Diality Inc · Series B Raised $42.9M · modeled $337.4M (est)VA Pro 7 SNF Operations Holdings LLC · Series B Raised $32.0M · modeled $333.0M (est)VivoSense, Inc. · Series B Raised $27.0M · modeled $332.3M (est)Tidal Wave GPO, LLC · Series B Raised $34.8M · modeled $324.3M (est)Peachy Corp. · Series B Raised $25.1M · modeled $309.6M (est)Smile Source Holdings, L.P. · Series B Raised $32.2M · modeled $308.7M (est)ASC San Rafael LLC · Series B Raised $28.3M · modeled $294.9M (est)Channel Medsystems, Inc. (this company) Raised $54.7M · modeled $35.8M (est)Channel Medsystems, Inc.
CompanyStageRaised · realValue · estvs peer med.
Code Biotherapeutics, Inc.Series B$47.5M$465.5M3.06×
Candesant Biomedical, Inc.Series B$44.5M$455.0M2.99×
Artis Holdings, LLCSeries B$40.0M$383.2M2.52×
GIO Blood LtdSeries B$27.3M$375.2M2.47×
Clarapath, Inc.Series B$40.2M$348.1M2.29×
Diality IncSeries B$42.9M$337.4M2.22×
VA Pro 7 SNF Operations Holdings LLCSeries B$32.0M$333.0M2.19×
VivoSense, Inc.Series B$27.0M$332.3M2.19×
Tidal Wave GPO, LLCSeries B$34.8M$324.3M2.13×
Peachy Corp.Series B$25.1M$309.6M2.04×
Smile Source Holdings, L.P.Series B$32.2M$308.7M2.03×
ASC San Rafael LLCSeries B$28.3M$294.9M1.94×
Channel Medsystems, Inc. this companySeries B$54.7M$35.8M0.24×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$9.8M2013-04-19$44.5M$197.5M85%
Series A$6.0M2014-10-07$27.3M$121.1M85%
Series B$23.9M2015-07-08$132.6M$528.7M85%
Series B$10.0M2023-04-19$55.6M$94.4M90%
Series B$5.0M2024-03-15$27.8M$35.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$9.8M2013-04-19
    • First recorded raise — entered as Series A.
    • 11 investors on this round.
  2. Series A$6.0M2014-10-07
    • Raised 18 mo later, in step with the ~14 mo sector norm.
    • Round 1.6× smaller than the prior — bridge or down round.
    • Switched to Rule 506(b) (was Rule 06).
    • 9 investors on this round.
  3. Series B$23.9M2015-07-08
    • Raised 9 mo later, in step with the ~14 mo sector norm.
    • Round 4.0× larger than the prior — scaling up.
    • 23 investors on this round.
  4. Series B$10.0M2023-04-19
    • Raised again after 93 mo — slower than the ~14 mo sector norm.
    • Round 2.4× smaller than the prior — bridge or down round.
    • 3 investors on this round.
  5. Series B$5.0M2024-03-15
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 2.0× smaller than the prior — bridge or down round.
    • 1 investor on this round.
Intelligence
2026 ~Q4
Modeled next raise · ~33mo cadence
$5.0M
Modeled next size est.range $5.0M$8.0M
0.5×
Last step-up
$5.0M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Carter Meyer13 other2013-04
Daniel Burnett10 other2013-04
Andrew Farquharson3 other2013-04
Anthony Natale3 other2013-04
Richard Emmitt2 other2023-04
Ian Vawter1 other2023-04
Bill Malecki2013-04
Carter Mayer2015-07
Dr. Jason Hong2015-07
Heather Knight2023-04
Jigar Choksey2023-04
Lisa Garett2023-04
Tim Berkowitz2023-04
Ulric Cote2013-04
William Malecki2023-04
Registry & provenance

Channel Medsystems, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1575310
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Venus Concept Ltd.Other Health CareSeries B$66.5M$311.3Mnetwork1 shared operator · same sector · same stage
Potrero Medical, Inc.BiotechnologySeries B$76.2M$9.9Mnetwork2 shared operators · same stage
Spirair, Inc.Other Health CareSeries B$24.7M$116.4Mnetwork1 shared operator · same sector · same stage
Centese, Inc.Other Health CareSeries B$15.6M$2.7Mnetwork1 shared operator · same sector · same stage
Impel Neuropharma IncOther Health CareSeries B$51.1M$34.4Msame sector · same stage
Summus Global, Inc.Other Health CareSeries B$59.3M$35.1Msame sector · same stage
Javara Inc.Other Health CareSeries B$59.7M$33.1Msame sector · same stage
Klowen Braces, Inc.Other Health CareSeries B$44.0M$31.9Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Able Channel, Inc.Other Health CarePre-Seed$2.1M89%
CareView Communications IncOther Health CareSeries B$2.7M84%
SOC Telemed, Inc.Other Health CareSeries C$1.9B84%
Relievant MedSystems IncOther Health CareSeries C$522.9M84%
Avail Medsystems, Inc.Other Health CareSeries C$2.2B84%
Navya Network, Inc.Other Health CarePre-Seed$15.4M84%
BridgepointMD, Inc.Other Health CareSeed$12.8M84%
Biowave CorpOther Health CareSeed$33.0M83%
Frequently asked
How much funding has Channel Medsystems, Inc. raised?
Channel Medsystems, Inc. has raised approximately $54.7M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Channel Medsystems, Inc.'s estimated valuation?
Provath's modeled valuation for Channel Medsystems, Inc. is approximately $35.8M (modeled range $11.8M–$67.7M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Channel Medsystems, Inc. at?
Channel Medsystems, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Fri Mar 15.
What does Channel Medsystems, Inc. do and where is it based?
Channel Medsystems, Inc. operates in the Other Health Care sector, based in BERKELEY.
Explore related

See where Channel Medsystems, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Channel Medsystems, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.